
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance
Maria V. Babak, Dohyun Ahn
Biomedicines (2021) Vol. 9, Iss. 8, pp. 852-852
Open Access | Times Cited: 143
Maria V. Babak, Dohyun Ahn
Biomedicines (2021) Vol. 9, Iss. 8, pp. 852-852
Open Access | Times Cited: 143
Showing 1-25 of 143 citing articles:
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Valentina Oliveri
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 279
Valentina Oliveri
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 279
A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma
Zilong Bian, Rong Fan, Lingmin Xie
Genes (2022) Vol. 13, Iss. 5, pp. 851-851
Open Access | Times Cited: 263
Zilong Bian, Rong Fan, Lingmin Xie
Genes (2022) Vol. 13, Iss. 5, pp. 851-851
Open Access | Times Cited: 263
Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
Shengxian Xu, Dongze Liu, Taihao Chang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 87
Shengxian Xu, Dongze Liu, Taihao Chang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 87
The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets
Jelle J. F. Sleeboom, Gilles van Tienderen, Katja Schenke‐Layland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 84
Jelle J. F. Sleeboom, Gilles van Tienderen, Katja Schenke‐Layland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 84
Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy
Jiao Chang, Weimin Yin, Hui Zhi, et al.
Small (2024) Vol. 20, Iss. 27
Closed Access | Times Cited: 22
Jiao Chang, Weimin Yin, Hui Zhi, et al.
Small (2024) Vol. 20, Iss. 27
Closed Access | Times Cited: 22
Relationship between copper and immunity: The potential role of copper in tumor immunity
Fu Cheng, Peng Geng, Yan Lu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 67
Fu Cheng, Peng Geng, Yan Lu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 67
New anti-cancer explorations based on metal ions
Han Hu, Qi Xu, Zhimin Mo, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 66
Han Hu, Qi Xu, Zhimin Mo, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 66
Copper-Catalyzed Glutathione Oxidation is Accelerated by the Anticancer Thiosemicarbazone Dp44mT and Further Boosted at Lower pH
Enrico Falcone, Alessandra Gilda Ritacca, Sonja Hager, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 32, pp. 14758-14768
Open Access | Times Cited: 49
Enrico Falcone, Alessandra Gilda Ritacca, Sonja Hager, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 32, pp. 14758-14768
Open Access | Times Cited: 49
Zinc–Carnosine Metallodrug Network as Dual Metabolism Inhibitor Overcoming Metabolic Reprogramming for Efficient Cancer Therapy
Lingling Lei, Bin Nan, Fengrui Yang, et al.
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2659-2668
Closed Access | Times Cited: 40
Lingling Lei, Bin Nan, Fengrui Yang, et al.
Nano Letters (2023) Vol. 23, Iss. 7, pp. 2659-2668
Closed Access | Times Cited: 40
Cu-related agents for cancer therapies
Chunhui Wang, Xinda Yang, Chunyan Dong, et al.
Coordination Chemistry Reviews (2023) Vol. 487, pp. 215156-215156
Closed Access | Times Cited: 29
Chunhui Wang, Xinda Yang, Chunyan Dong, et al.
Coordination Chemistry Reviews (2023) Vol. 487, pp. 215156-215156
Closed Access | Times Cited: 29
Effect of regulatory cell death on the occurrence and development of head and neck squamous cell carcinoma
Yu‐Ting Xue, Xuejiao Jiang, Junrong Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Yu‐Ting Xue, Xuejiao Jiang, Junrong Wang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Targeting copper metabolism: a promising strategy for cancer treatment
Ruimin Kong, Guojuan Sun
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
Ruimin Kong, Guojuan Sun
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
Research progress on cuproptosis in cancer
Qingbo Feng, Chenyu Huo, Maijian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Qingbo Feng, Chenyu Huo, Maijian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
Xiaojie Zhang, Bufu Tang, Jinhua Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Xiaojie Zhang, Bufu Tang, Jinhua Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Pan‐cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators
Changwu Wu, Jun Tan, Xiangyu Wang, et al.
iMeta (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 34
Changwu Wu, Jun Tan, Xiangyu Wang, et al.
iMeta (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 34
Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
Xingyu Peng, Jinfeng Zhu, Sicheng Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Xingyu Peng, Jinfeng Zhu, Sicheng Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
The coordination modes of (thio)semicarbazone copper(II) complexes strongly modulate the solution chemical properties and mechanism of anticancer activity
Vivien Pósa, Bálint Hajdu, Gábor G. Tóth, et al.
Journal of Inorganic Biochemistry (2022) Vol. 231, pp. 111786-111786
Closed Access | Times Cited: 31
Vivien Pósa, Bálint Hajdu, Gábor G. Tóth, et al.
Journal of Inorganic Biochemistry (2022) Vol. 231, pp. 111786-111786
Closed Access | Times Cited: 31
Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas
Shouyi Tang, Li Zhao, Xing-Bo Wu, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3986-3986
Open Access | Times Cited: 29
Shouyi Tang, Li Zhao, Xing-Bo Wu, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3986-3986
Open Access | Times Cited: 29
Cuproptosis: emerging biomarkers and potential therapeutics in cancers
Min Wang, Lianwen Zheng, Shuai Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Min Wang, Lianwen Zheng, Shuai Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
Xiaoqiang Wang, Dongfang Chen, Yumiao Shi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Xiaoqiang Wang, Dongfang Chen, Yumiao Shi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Review on carbon dots: Synthesis and application in biology field
Xueting Li, Lidong Yu, Mingyue He, et al.
BMEMat (2023) Vol. 1, Iss. 4
Open Access | Times Cited: 17
Xueting Li, Lidong Yu, Mingyue He, et al.
BMEMat (2023) Vol. 1, Iss. 4
Open Access | Times Cited: 17
Mitochondria‐Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death‐1 Downregulation for Cancer Immunotherapy
Youyou Li, Jing Liu, Ralph R. Weichselbaum, et al.
Advanced Science (2024)
Open Access | Times Cited: 7
Youyou Li, Jing Liu, Ralph R. Weichselbaum, et al.
Advanced Science (2024)
Open Access | Times Cited: 7
Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Ruiwen Zhao, Olga Sukocheva, Edmund C. M. Tse, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Advancements in Breast Cancer Therapy: The Promise of Copper Nanoparticles
C Surya, Ashoka Babu Vechham Lakshminarayana, Sameera Hammigi Ramesh, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 86, pp. 127526-127526
Closed Access | Times Cited: 7
C Surya, Ashoka Babu Vechham Lakshminarayana, Sameera Hammigi Ramesh, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 86, pp. 127526-127526
Closed Access | Times Cited: 7
Is Copper Still Safe for Us? What Do We Know and What Are the Latest Literature Statements?
Angelika Edyta Charkiewicz
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8441-8463
Open Access | Times Cited: 6
Angelika Edyta Charkiewicz
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8441-8463
Open Access | Times Cited: 6